Breaking News

HSN appointed Matthew Rubel to its board of directors

November 4, 2013

HSN: appointed Matthew Rubel to its board of directors. He currently serves as a senior advisor with TPG Capital, a leading global private investment firm with more than $50 billion of capital under management.

Until 2011, Rubel was the chairman, president and chief executive officer of Collective Brands, a leading retailer and marketer. Rubel joined Collective Brands in 2005 as chief executive officer and president. His merchandising and retailing background includes serving as chairman, president and CEO of Cole Haan, executive vice president of J. Crew Group and CEO of Popular Club Plan. At Revlon he was president of the specialty store division.  In addition, as a White House appointee, Rubel serves on the United States Trade Representative (USTR) Advisory Committee for Trade Policy and Negotiations.
blog comments powered by Disqus
  • What’s New at La Prairie?

    What’s New at La Prairie?

    Melissa Meisel, Associate Editor||April 25, 2016
    VP of marketing shares the latest buzz with Happi.

  • Mapping Out Multicultural Beauty

    Mapping Out Multicultural Beauty

    April 25, 2016
    Agnieszka Saintemarie of Kline Group about current trends and challenges in multicultural beauty.

  • At a Loss for Curls?

    April 22, 2016
    Amplixin, a Miami-based maker of hair strengthening products, has a solution for hair loss.

  • Who Makes That?

    Who Makes That?

    Tom Branna, Editorial Director||April 1, 2016
    From concept and formulation to testing and filling, today’s contract manufacturers perform a range of services for marketers

  • Multi-Cultural Beauty Update

    Multi-Cultural Beauty Update

    Christine Esposito, Associate Editor||April 1, 2016
    Established brands and start-ups address the needs of multi-cultural beauty consumers.

  • The Scalp Microbiome

    The Scalp Microbiome

    Nava Dayan PhD, Dr. Nava Dayan LLC||April 1, 2016
    A review of recent findings and innovative approaches for treating scalp disorders.